IJGC Podcast

In this episode of the IJGC podcast, Dr. Pedro Ramirez interviews Dr. Michael Frumovitz about his recent publication in Lancet Oncology on the quality of life endpoints from the LACC trial. Tune in! You might be very surprised with their results!

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Samantha Cabral to discuss neoadjuvant chemotherapy in locally advanced cervical cancer and the CIRCE Trial. Dr. Cabral is an clinical oncologist doctor specialized in gynecological cancer. She works at the Instituto do Cancer do Estado de São Paulo, a public school hospital, attending patients, teaching fellows students in oncology. Dr. Cabral also works with clinical research in gynecological cancer with special interests in cervical cancer.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Mario Leitao to discuss lower extremity lymphedema in gynecologic oncology. Dr. Mario Leitao is currently an Attending Surgeon in the Department of Surgery at Memorial Sloan Kettering Cancer Center and a Professor in the Department of Obstetrics and Gynecology at Weill Cornell Medical College. He currently serves as Program Director for the Gynecologic Oncology Fellowship. Dr. Leitao is also the Director for the Minimal Access and Robotic Surgery Program in the Department of Surgery for MSKCC.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jennifer Mueller to discuss genomic profiling of ultra-low risk endometrial cancer. Her article, "Clinical patterns and genomic profiling of recurrent ‘ultra-low risk’ endometrial cancer," (https://ijgc.bmj.com/content/early/2020/05/04/ijgc-2020-001241) is the lead article in the June 2020 issue of IJGC. Dr. Mueller is a gynecologic oncologist and assistant attending in the department of surgery at Memorial Sloan Kettering Cancer Center. She helps lead the endometrial cancer research team at MSKCC with an emphasis on prospective, translational and collaborative efforts within and across institutions.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Robert Coleman to for a summary discussion of the VELIA trial.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Terri L. Woodard to discuss fertility and ovarian function preservation in women with cancer. Dr. Woodard is a board-certified reproductive endocrinologist and infertility specialist with expertise in the field of oncofertility. She is the Founder and Director of the MD Anderson Oncofertility Program and holds a joint appointment as an Associate Professor in the Division of Reproductive Endocrinology and Infertility at Baylor College of Medicine.

Dr. Koji Matsuo is Associate Professor and Chief of the Oncology Research in the Division of Gynecologic Oncology at University of Southern California. Koji Matsuo, MD, PhD, is an Associate Professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Southern California. Dr. Matsuo’s research focuses on outcomes research in gynecologic malignancies.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Yan Xiaojian to discuss open vs. MIS radical hysterectomy

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Katherine Kurnit to discuss GI-based chemotherapy in ovarian mucinous cancers. Dr. Kurnit is an Assistant Professor at the University of Chicago in the section of Gynecologic Oncology. Her research interests include developmental therapeutics and early phase clinical trials for women with gynecologic malignancies.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Alexey Shevchuk to discuss the current state of gynecologic oncology in Russia. Dr. Shevchuk is a gynecologic oncologist in Moscow, Russia and engaged in collaborative partnerships with IGCS and the American Eurasian Cancer Alliance (AECA).